BookFronter
The LDN Book by Linda Elsegood

The LDN Book

How a Little-known Generic Drug Low Dose Naltrexone Could Revolutionize Treatment for Autoimmune Diseases, Cancer, Autism, Depression, and More

Linda Elsegood

Rizzoli · Print & ebook · February 1, 2016

Could a little-known drug really revolutionize treatment for autoimmune diseases, cancer, depression, and more? “[LDN] raises hopes of reversing memory loss in old age.”—the Guardian Over 30,000 copies sold!

CancerImmune System DisordersChronic Fatiguehealth
More
healingmedical
Buy on Amazon

We earn from qualifying purchases.

Who it’s for
A compact, surprisingly readable look at a little-known drug and the questions around it.
Genres
Immune System Disorders, Cancer, Chronic Fatigue
Published
Rizzoli, February 1, 2016

Nearest books

Matched by what the books are about, then ordered by what their readers also loved.

  1. Healing With DMSOAmandha Dawn Vollmer45% match
  2. The Metabolic Approach to CancerNasha Winters, Jess Higgins Kelley46% matchShares Cancer
  3. Healing ArthritisSusan Blum MD MPH, Michele Bender44% matchShares Immune System Disorders
  4. Medical Medium Liver RescueAnthony William53% match
  5. The New Arthritis BreakthroughHenry Scammell51% matchShares Immune System Disorders
  6. The End of Alzheimer'sDale Bredesen, Dale E. Bredesen51% match
  7. Dirty GenesDr. Ben Lynch, Ben Lynch51% match

Start with three books, and this one can be the first.

Members get a new edition every morning: a route out from their books to essays, research and talks, with the reason for each.

Start with this book

About this book

Could a little-known drug really revolutionize treatment for autoimmune diseases, cancer, depression, and more? “[LDN] raises hopes of reversing memory loss in old age.”—the Guardian Over 30,000 copies sold! Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers, and even autism, chronic fatigue, and depression, find relief.

Continue reading

Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects. So why has it languished in relative medical obscurity? The LDN Book explains: - The drug’s origins - Its primary mechanism - The latest research from practicing physicians and pharmacists Compiled by Linda Elsegood of The LDN Research Trust—the world’s largest LDN charity organization with over 19,000 members worldwide—the book features ten chapters contributed by medical professionals on LDN’s efficacy and two patient-friendly appendices. The LDN Book is a comprehensive resource for doctors, pharmacists, and patients who want to learn more about how LDN is helping people now, and a clarion call for further research that could help millions more.

Small Drug, Big Questions

A compact, surprisingly readable look at a little-known drug and the questions around it.

Come here for

  • Low-dose, high-curiosity medicine
  • A hybrid of explanation and lived-use reading

Expect

  • Clinical terrain, not bedside reassurance
  • Book-to-reference use, with some narrative pull

Where it sits

Immune System Disorders46%
Cancer30%
Chronic Fatigue27%

Percentages are BookFrontier’s reading of the book.

Publisher categories

  • Health & Wellness
  • Cancer
  • Immune System Disorders
Authors
Linda Elsegood
Publisher
Rizzoli
Published
February 1, 2016
Format
Print & ebook
Reading lane
Health & Wellness